Drug administration device for urinary system inflammation
Technical Field
The invention relates to a medical appliance, in particular to a drug administration device for urinary system inflammation.
Background
For various reasons, some patients can suffer from the inflammation of the urinary system, and after the patients suffer from the inflammation, the patients need to take the medicine in time for treatment, but the oral medicine needs to be absorbed by human bodies and then acts on the affected parts, and the medicine cannot directly reach the affected parts, so the treatment effect is relatively slow and poor. In order to obtain a quick and good treatment effect, when a patient suffers from a disease, the patient can be directly used with medicine, the method adopted at present is to directly spray liquid medicine to the patient by using a common flusher, but in order to avoid cross infection, the flusher needs to be strictly disinfected after use, so that more workload is brought to medical staff, otherwise, the flusher needs to be discarded, and the waste of instruments is caused. Moreover, when the flusher is used for treatment, dirt and waste liquid in the body can easily enter the flusher, so that the medicine is polluted, the medicine effect is not fully exerted, and waste is caused.
Disclosure of Invention
Aiming at the defects, the invention provides the drug delivery device for the inflammation of the urinary system, which can save materials and avoid waste.
The technical scheme for solving the technical problems is as follows:
an administration device for urinary system inflammation comprises a sleeve, wherein the front end of the sleeve is fixedly communicated with a connecting pipe in a closed manner, and the administration device is characterized in that the outer diameter of the front end of the connecting pipe is smaller than that of the rear end of the connecting pipe, the outer contour of the connecting pipe is in the shape of a circular truncated cone, an injection pipe which is communicated with the connecting pipe in a closed manner and has elasticity at the rear end part is movably inserted outside the connecting pipe, elastic locating lantern rings are movably sleeved outside the injection pipe at the front and rear parts of the part connected with the connecting pipe in a front-and-back manner, the locating lantern rings are in the; the connecting rod has all been stretched out outside the connecting tube to the both ends of connecting rod, the limit baffle before connecting rod front end fixedly connected with, the external diameter of preceding limit baffle is greater than the preceding port internal diameter of connecting tube, preceding limit baffle is with the preceding port shutoff of connecting tube behind the connecting tube, limit baffle behind connecting rod rear end fixedly connected with, the external diameter of back limit baffle is greater than the back port internal diameter of connecting tube, seted up a plurality of liquid holes of crossing on the back limit baffle, cross the liquid hole and communicate sleeve and connecting tube.
The administration device for the urinary system inflammation is characterized in that a plurality of connecting rods are fixedly connected between the front limiting baffle and the rear limiting baffle, and the connecting rods are arranged close to the inner wall of the connecting pipe.
The administration device for the inflammation of the urinary system is characterized in that at least three connecting rods are fixedly connected between the front limiting baffle and the rear limiting baffle.
The drug feeder for the inflammation of the urinary system is characterized in that the front end of the injection tube is hermetically communicated with an injection bag, the side wall of the injection bag is provided with a plurality of injection ports, the side wall of the injection bag in the injection port is sequentially connected with a liquid return prevention baffle, a liquid return prevention inner valve and a liquid return prevention outer valve from inside to outside, the liquid return prevention baffle is provided with a liquid outlet hole, the liquid return prevention inner valve and the liquid return prevention baffle are attached together and are shielded outside the liquid outlet hole, and the liquid return prevention outer valve and the liquid return prevention inner valve are attached together and are shielded outside the free opening side of the liquid return prevention inner valve.
The drug delivery device for the urinary system inflammation is characterized in that the liquid outlet hole is formed in the center of the liquid return prevention baffle, the centers of two side faces of the liquid return prevention baffle are both inwards sunken to form a horn mouth shape, the front projection of the liquid return prevention inner valve is larger than 1/2 circles, and the front projection of the liquid return prevention outer valve is smaller than 1/2 circles.
The drug delivery device for the inflammation of the urinary system is characterized in that a piston is connected in the sleeve in a sliding and sealing mode from front to back, the piston is fixedly connected with a push rod, and the rear end of the push rod penetrates out of the rear port of the sleeve and is fixedly connected with an integrated push handle.
The drug feeder for the inflammation of the urinary system is characterized in that an outer baffle is integrally and fixedly connected to the front end of the push rod, a penetrating rod is integrally and fixedly connected to the front side of the outer baffle and penetrates through the center of the piston, an inner blocking ring is in threaded connection with the penetrating rod on the front side of the piston, and the piston is hermetically and fixedly connected with the penetrating rod through the outer baffle and the inner blocking ring.
The administration device for the urinary system inflammation is characterized in that a sealing ring is integrally and fixedly connected to the front side face of the outer baffle, the penetrating rod is located in the middle of the sealing ring, and the piston is in close contact with the sealing ring.
The administration device for the urinary system inflammation is characterized in that the middle of the front side surface of the piston is recessed backwards to form a pit, and the pit is in a circular truncated cone shape.
The administration device for the urinary system inflammation is characterized in that the front side surface of the inner baffle ring is integrally and fixedly connected with a rotary lug; an anti-drop ring is fixedly connected outside the sleeve in an integrated mode.
The invention adopts an assembled structure, and the sleeve part for injection can be repeatedly used, thereby saving the materials of the apparatus and avoiding the waste.
Drawings
FIG. 1 is a schematic structural view of the present invention;
FIG. 2 is a schematic view of the structure of an injection port according to the present invention;
FIG. 3 is a schematic diagram of the right side view of FIG. 2;
FIG. 4 is an enlarged view of part A of FIG. 1;
FIG. 5 is a bottom view of the assembly of the front limit stop and the connecting rod of the present invention.
In the drawings:
1. a push handle; 2. a push rod; 3. the anti-drop ring; 4. a sleeve; 5. an outer baffle; 6. a seal ring; 7. penetrating a rod; 8. a piston; 9. an inner baffle ring; 10. rotating the lug; 11. a connecting pipe; 12. an injection tube; 13. a positioning collar; 14. an injection balloon; 15. an injection port; 16. a liquid outlet hole; 17. a liquid return prevention baffle; 18. an anti-fluid-return inner valve; 19. an anti-fluid-return outer valve; 20. a front limit baffle; 21. a connecting rod; 22. a rear limit baffle; 23. and (4) liquid passing holes.
Detailed Description
The principles and features of this invention are described below in conjunction with the following drawings, which are set forth by way of illustration only and are not intended to limit the scope of the invention.
As shown in fig. 1 to 5, an administration device for inflammation of urinary system comprises a sleeve 4, the front end of the sleeve 4 is fixedly communicated with a connecting pipe 11 in a sealing way, the outer diameter of the front end of the connecting pipe 11 is smaller than that of the rear end thereof, the outer contour of the connecting pipe 11 is in the shape of a circular truncated cone, an injection pipe 12 which is communicated with the connecting pipe 11 in a sealing way and has elasticity at the rear end thereof is movably inserted outside the connecting pipe 11, a positioning sleeve ring 13 with elasticity is movably sleeved outside the injection pipe 12 at the connecting part of the connecting pipe 11 in the front and rear directions, the positioning sleeve ring 13 is in the shape of a circular ring, the cross section of the positioning sleeve ring 13 is; connecting rod 21 has been alternate in 11 internalization of connecting pipe, connecting rod 21's both ends all stretch out outside connecting pipe 11, limit baffle 20 before connecting rod 21 front end fixedly connected with, the external diameter of preceding limit baffle 20 is greater than the front port internal diameter of connecting pipe 11, preceding limit baffle 20 contacts the back with connecting pipe 11 and the shutoff of the front port of connecting pipe 11, limit baffle 22 behind connecting rod 21 rear end fixedly connected with, the external diameter of back limit baffle 22 is greater than the back port internal diameter of connecting pipe 11, a plurality of liquid holes 23 of crossing have been seted up on the back limit baffle 22, cross liquid hole 23 and communicate sleeve 4 and connecting pipe 11.
In this embodiment, a plurality of the connecting rods 21 are fixedly connected between the front limit baffle 20 and the rear limit baffle 22, and the connecting rods 21 are arranged closely to the inner wall of the connecting pipe 11. At least three connecting rods 21 are fixedly connected between the front limit baffle 20 and the rear limit baffle 22.
During the injection treatment, the piston 8 moves forwards, the liquid medicine enters the connecting pipe 11 through the liquid passing hole 23 and pushes the front limit baffle 20 to move forwards, and then the liquid medicine enters the injection pipe 12 and flows out of the injection bag 14 to treat the patient. After the injection is finished, the piston 8 is pulled backwards slightly, the liquid medicine in the injection tube 12 flows backwards, and meanwhile the front limiting baffle 20 is pushed backwards, so that the front port of the connecting tube 11 is blocked, at the moment, the positioning lantern ring 13 can be turned forwards to be detached, the injection tube 12 and the injection bag 14 are taken down, and the sleeve part is not polluted, so that the injection tube is not required to be disinfected, can be reused and avoids waste.
In this embodiment, the front end of the injection tube 12 is hermetically communicated with an injection bag 14, a plurality of injection ports 15 are formed in the side wall of the injection bag 14, a liquid return prevention baffle 17, a liquid return prevention inner valve 18 and a liquid return prevention outer valve 19 are sequentially connected to the side wall of the injection bag 14 in the injection ports 15 from inside to outside, liquid outlet holes 16 are formed in the liquid return prevention baffle 17, the liquid return prevention inner valve 18 and the liquid return prevention baffle 17 are attached together and shielded outside the liquid outlet holes 16, and the liquid return prevention outer valve 19 and the liquid return prevention inner valve 18 are attached together and shielded outside the free opening side of the liquid return prevention inner valve 18.
The liquid outlet 16 is arranged at the center of the liquid return prevention baffle 17, the centers of two side surfaces of the liquid return prevention baffle 17 are both inwards sunken to form a horn mouth shape, the front projection of the liquid return prevention inner valve 18 is larger than 1/2 circles, and the front projection of the liquid return prevention outer valve 19 is smaller than 1/2 circles.
A piston 8 is connected in the sleeve 4 in a sliding and sealing mode, the piston 8 is fixedly connected with a push rod 2, and the rear end of the push rod 2 penetrates out of the rear end opening of the sleeve 4 and is fixedly connected with an integrated push handle 1.
The integrated fixed connection of 2 front ends of push rod has outer baffle 5, and the integrated fixed connection of 5 front sides of outer baffle has pole 7, wears pole 7 and follows piston 8's center passes, and threaded connection has interior fender ring 9 on the pole 7 of piston 8 front side, and piston 8 keeps off ring 9 and wears pole 7 airtight fixed continuous through outer baffle 5 and interior.
The front side surface of the outer baffle 5 is integrally and fixedly connected with a sealing ring 6, the penetrating rod 7 is positioned in the middle of the sealing ring 6, and the piston 8 is in airtight contact with the sealing ring 6.
The middle part of the front side surface of the piston 8 is recessed backwards to form a pit, and the pit is in a circular truncated cone shape.
The front side surface of the inner baffle ring 9 is integrally and fixedly connected with a rotary lug 10; an anti-drop ring 3 is fixedly connected outside the sleeve 4 integrally.